Earlier this month, UK pharmaceutical and “consumer healthcare” conglomerate GSK took a look at its Lucozade and Ribena brands, and set itself a choice: Does it sell the two, or does it look at setting up an investment programme? Richard Corbett considers the firm’s dilemma.
Subscribe to Just Drinks for just £1 for 1 month
Stay ahead with unbiased news, expert commentary, and in-depth features on global topics.
As a trusted provider of data and insights, Just Drinks collaborates closely with industry leaders and professionals to offer unique thought leadership and analysis. Gain a deeper understanding of the apparel industry’s trajectory and the priorities shaping the profession.
What’s included in your subscription:
- Personalized Access: Secure login to Just Drinks
- Industry News & Expert Commentary: Timely updates and exclusive C-level interviews.
- Case Studies & Deep Dives: Real-world applications and in-depth analyses.
- Exclusive Subscriber Newsletter: Weekly top features, plus a new thematic report and webinar.
Ready to stay informed?
